Market Overview

Jefferies Downgrades Ampio Pharmaceuticals To Hold

Related AMPE
42 Biggest Movers From Yesterday
37 Stocks Moving In Tuesday's Mid-Day Session
Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/22/2018) (Seeking Alpha)

Analysts at Jefferies downgraded Ampio Pharmaceuticals (NYSE: AMPE) from Buy to Hold.

The target price for Ampio Pharmaceuticals has been lowered from $14 to $5.

Ampio Pharmaceuticals shares have fallen 15.02% over the past 52 weeks, while the S&P 500 index has surged 19.77% in the same period.

Ampio Pharmaceuticals' shares rose 0.71% to $5.70 in pre-market trading.

Latest Ratings for AMPE

Aug 2014JefferiesDowngradesBuyHold
Jun 2014JefferiesInitiates Coverage onBuy
May 2014Citigroup

View More Analyst Ratings for AMPE
View the Latest Analyst Ratings

Posted-In: JefferiesDowngrades Analyst Ratings


Related Articles (AMPE)

View Comments and Join the Discussion!